APOA1 and atherosclerosis: Fuxue Deng et al. studied 320 atherosclerotic cardiovascular disease (ASCVD) patients treated with PCI to analyze the association between ApoB/ApoA1 and coronary vulnerable plaque; plaque rupture, erosion, and thrombosis were found to be independently predicted by the ApoB/ApoA1 ratio in individuals with ASCVD [34].